Results 91 to 100 of about 31,346 (264)

Malignant lymphomas in transplantation patients: a review of the world experience. [PDF]

, 1970
Malignant lymphomas developed in 9 renal homograft recipients treated at widely separated transplantation centers. The development of these tumors appears to be an indirect complication of organ transplantation and/or the measures taken to prevent ...
Penn, I, Starzl, TE
core  

Predictors of post-thymectomy long-term neurological remission in thymomatous myasthenia gravis: an analysis from a multi-institutional database.

European Journal of Cardio-Thoracic Surgery, 2019
OBJECTIVES Thymectomy is the treatment of choice for thymomatous myasthenia gravis (MG) for both oncological and neurological aspects. However, only a few studies comprising small numbers of patients have investigated post-thymectomy neurological ...
K. J. Na, K. Hyun, C. Kang, Samina Park, Hyun Joo Lee, I. Park, Young Tae Kim, G. Lee, H. Kim, S. Choi, Yong-Hee Kim, D. K. Kim, Seung-Il Park, Sumin Shin, J. Cho, H. Kim, Y. Choi, Jhingook Kim, J. Zo, Y. Shim, Chang Young Lee, J. Lee, Dae Joon Kim, H. Paik, K. Chung   +24 more
semanticscholar   +1 more source

Robotic Extended Thymectomy in Late‐Onset Myasthenia Gravis: A 21‐Year Retrospective Cohort Study of 172 Patients

European Journal of Neurology, Volume 32, Issue 11, November 2025.
This 21‐year retrospective cohort study evaluated the safety and long‐term outcomes of robotic extended thymectomy in 172 patients with late‐onset myasthenia gravis (onset age ≥ 50 years). Both late‐ and very late‐onset subgroups showed comparable perioperative outcomes and achieved favorable neurological remission. A significant corticosteroid‐sparing
Luyu Huang, Feng Li, Zhongmin Li, Hongbin Zhang, Aron Elsner, Julia Strauchmann, Marco Nicolas Andreas, Tomasz Dziodzio, Aina Lask, Jens Neudecker, Daipeng Xie, Lintong Yao, Shaowei Wu, Haiyu Zhou, Andreas Meisel, Jens‐C. Rueckert   +15 more
wiley   +1 more source

Descriptive analysis of therapeutic outcomes between thoracoscopic and transsternal thymectomy in myasthenia gravis patients from 2011 to 2021

Journal of Cardiothoracic Surgery
Background Myasthenia gravis is an autoimmune disease with high prevalence of thymus disorders, in which, thymectomy is considered one of the therapeutic approaches in improving the patients’ clinical outcomes.
Mahdiye Lashkarizadeh, Vahid Haghollahi, Nazanin Zeinali Nezhad, Mohammadreza Lashkarizadeh, Amirhossein Shahpar   +4 more
doaj   +1 more source

Thymoma with Myasthenia Gravis in Adolescent [PDF]

, 2011
Thymomas are exceedingly rare in the first 20 years of life, Thymic lesions comprise approximately 2–3% of all pediatric mediastinal tumors and include thymic cysts, hyperplasia, carcinoma, and thymomas.
Balaiah, K, Nayak, Ganesh, Shetty, Prasad K, Shetty, Prasanna K   +3 more
core   +1 more source

Rituximab in New‐Onset Generalized Myasthenia Gravis: Long‐Term Follow‐Up of the RINOMAX Clinical Trial

European Journal of Neurology, Volume 32, Issue 11, November 2025.
A potential long‐term benefit of rituximab was noted for MG maintenance, though the risk of infection remains a concern. ABSTRACT Background The placebo‐controlled RINOMAX trial (NCT02950155) demonstrated superiority up to 12 months of rituximab over standard‐of‐care in new‐onset generalized myasthenia gravis (MG), but benefit–risk over longer time ...
Jing Wu, Ann Eriksson‐Dufva, Anna Budzianowska, Amalia Feresiadou, William Hansson, Max Albert Hietala, Irene Håkansson, Rune Johansson, Daniel Jons, Ivan Kmezic, Christopher Lindberg, Jonas Lindh, Fredrik Lundin, Ingela Nygren, Anna Rostedt Punga, Rayomand Press, Kristin Samuelsson, Peter Sundström, Oskar Wickberg, Thomas Frisell, Susanna Brauner, Fredrik Piehl   +21 more
wiley   +1 more source

Thymic hyperplasia as a rare etiology of pure red cell aplasia: A case report [PDF]

Vojnosanitetski Pregled
Introduction. Thymic hyperplasia is a rare condition caused by an increase in cellular thymic mass and, in some cases, is associated with autoimmune diseases, such as pure red cell aplasia (PRCA).
Arsenović Isidora, Leković Danijela, Šefer Dijana, Pavlović Miroslav, Ivanović Jelena, Smiljanić Mihailo, Bogdanović Andrija   +6 more
doaj   +1 more source

Thymectomy in ocular myasthenia gravis—prognosis and risk factors analysis

Orphanet Journal of Rare Diseases, 2022
Background Several retrospective studies have identified risk factors associated with ocular myasthenia gravis (OMG) generalization in non-surgical patients. However, the outcomes of OMG after thymectomy have not been investigated fully. This study aimed
Jinwei Zhang, Zeyang Zhang, Hui Zhang, Yuantao Cui, Yuan Chen, Peng Lv, Peng Zhang   +6 more
doaj   +1 more source

Indirect induction of radiation lymphomas in mice. Evidence for a novel, transmissible leukemogen. [PDF]

, 1987
The transmission of a lymphomagenic agent(s) from the bone marrow of irradiated mice to thymic target cells has been demonstrated by: (a) the induction of T cell lymphomas in nonirradiated thymic grafts implanted in irradiated, Thy-l-congenic mice, (b ...
Hansteen, GA, Lieberman, M, McCune, JM, Scott, ML, Weissman, IL, White, JH   +5 more
core  

Early Flare-Ups of Myasthenia Gravis After Thoracoscopic Thymectomy in a Patient Recently Receiving BNT162b2 mRNA COVID-19 Vaccination [PDF]

, 2022
Permphan Dharmasaroja
openalex   +1 more source